Skip to main content

Vitamin B12 Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast

The global vitamin B12 market is exhibiting a huge growth with steady CAGR. Driving factors include cost-effectiveness, convenience and accessibility. Technology advancements and rising awareness regarding vitamin deficiency to boost market

Pune, India, March 09, 2023 (GLOBE NEWSWIRE) — The global vitamin B12 market size is expected to gain momentum owing to the rising prevalence of vitamin deficiency during the projected period. This information is published by Fortune Business Insights™ in an upcoming report, titled, “Vitamin B12 Market, 2023-2030”. Vitamin B is essential for the efficient cellular metabolism of the human body. It is highly found in animal food sources such as fish, eggs, meat, and poultry. Population having a plant-based diet that is vegetarian and vegan lack vitamin B12 as compared to non-vegetarians. According to the National Institute for Health and Care Excellence, vitamin B12 deficiency is around 6% among the population aged below 60 years, which is expected to drive the market.


Get a Free Sample Research PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vitamin-b12-market-104816


Industry Development:

The Food Safety and Standards Authority of India (FSSAI), issued a letter lifting the ban on the production of methylcobalamin in Gujarat, India.

The U.S FDA granted supplemental drug approval for CaloMist (cyanocobalamin nasal spray) manufactured by Par Pharmaceutical, New York.

Report Scope:

Report CoverageDetails
Forecast Period2023 to 2030
Base Year2022
Historical Data2019 to 2021


Key Takeaways:

  • The demand for Vitamin B12 supplements is increasing globally due to the rising awareness of the benefits of the vitamin.
  • Increased focus on the importance of Vitamin B12 supplementation, especially for those who may have a higher risk of deficiency.
  • The popularity of vegan and vegetarian diets is also driving the demand for Vitamin B12 supplements, as the vitamin is mostly found in animal products.

Drivers & Restraints:

Increasing Prevalence of Vitamin Deficiency to Bolster Market Expansion

The global vitamin B12 market growth is expected to rise due to the projected fear of vitamin deficiency among people during the forecast period. Increasing deficiency of vitamin B in the young generation and people having plant-based diets is a major factor to drive the market. Furthermore, according to the National Institute of Health, the global prevalence of vitamin B12 deficiency is around 15% in the general population, which is expected to enhance the market growth.

Whereas, lower awareness regarding vitamin deficiency in developing countries can hamper market development.      


Browse Report Details: https://www.fortunebusinessinsights.com/vitamin-b12-market-104816    


Report Coverage:

The report for the vitamin B12 market includes a detailed analysis of emerging market trends and industry developments. This market focuses on creating strategic partnerships, acquisitions, and mergers to improve productivity and industrial performance. New product development, technological innovation, and market expansion are highlighted further in this report. Market segmentation is performed to analyze global strategies and develop market reach.       

Segments:

By dosage form, the market is divided into syrups, injections, tablets, powder, and nasal spray.

On the basis of route of administration, the market is categorized into oral, intravenous, subcutaneous, and nasal.

Based on distribution channels, the market is trifurcated into hospital pharmacy, retail pharmacy, and online pharmacy.

Finally, by geography, the market is segmented into, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.  

By Dosage Form

  • Syrups
  • Injection
  • Tablets
  • Powder
  • Nasal Spray

By Route of Administration

  • Oral
  • Intravenous
  • Subcutaneous
  • Nasal

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Geography

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)


Pre Book – Vitamin B12 Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104816


Regional Insights:

Increasing Awareness of Vitamin Deficiency to Expand Market in North America

North America is expected to hold the largest global vitamin B12 market share during the forecast period. Increasing awareness regarding vitamin deficiency, a high sedentary lifestyle, and efficient availability of vitamin supplements are expected to influence the market expansion.

Europe is expected to hold a second-largest position in the global market. A higher population of vegetarians and vegans is expected to increase the demand for vitamin supplements to overcome vitamin deficiency. Increasing intake of vitamin supplements supports product demand in the region.    

Competitive Landscape:

Strategic Alliances by Key Players to Strengthen Market Position

Key players in the market focus on collaborating with healthcare providers to increase supplement production and supply to the population. Developing new products and implementing innovation allows competitors to serve major needs of people to overcome the deficiency. Creating strategic alliances and partnerships with supporting organisations will enhance product development and supply to the target segments ensuring market growth.  

List of Key Players Profiled in the Global Report for Vitamin B12 Market:

  • Mylan N.V (U.S.)
  • Pfizer Inc. (U.S.)
  • Merck & Co. (U.S.)
  • Dr. Reddy’s Laboratory (India)
  • Daiichi Sankyo Company (Japan)
  • Apotheca Inc. (U.S.)
  • American Regent Inc. (U.S.)


Ask for Customization: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/vitamin-b12-market-104816


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email:
 sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.